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STUDIES ON POST-ATABRINE DERMATITIS
II. PERMANENT ANHIDRosIs, ANHIDROTIC ASTHENIA AND PROLONGED
DERMATITIS FOLLOWING ATABRINE DERMATITIS *
IRA LEO SCIIAMBERG, M.D.
In a previous study (1), we observed the course of chronic or recurrent, often
bizarre dermatitis in a group of veterans of World War II who had suffered,
while overseas, from a generalized dermatitis designated at the time as atypical
lichen planus. Andrews (la) in 1938, and Becker and Obermayer (ib) in 1940,
listed atabrine as a cause of exfoliative dermatitis. Numerous other authors
(2—14) have since incriminated atabrine as the cause of so-called atypical lichen
planus. In all of the patients in our first study, and in some of those presented
in this second study, the acute process had tapered off over a period of months
to a chronic or remittent eczematous, lichenoid or weeping pruritic dermatitis.
There has been no name for this chronic disease—it mimics many dermatoses.
It appears clear to us that it follows and results from the acute atabrine derma-
titis incurred overseas, and in our first paper we therefore labelled it chronic
atabrine dermatitis. This term has caused confusion, in that it appears to imply
that the chronic dermatitis is the result of either continued atabrine ingestion
or continued action of atabrine in the patient's tissues. On the suggestion of
Dr. Walter Shelley, we therefore submit the name "Post-Atabrine Dermatitis",
as expressing more clearly our concept of this disease.
ETIOLOGY OF POST-ATABRINE DERMATITIS
Miller, Herrmann and Rubin (12) and Herrmann and Miller (13, 14) demon-
strated intense blue white fluorescence in sweat ducts in a patient who presented
a sweat retention syndrome six years after the onset of lichenoid atabrine
dermatitis. They suggest that traces of atabrine were still retained by the lining
of the terminal portions of the ducts as long as six years after the last ingestion
of atabrine. In patients given the drug experimentally by these workers, how-
ever, fluorescence of the skin, nails and sweat ducts persisted no longer than 14
weeks. Whether or not further study corroborates the persistence of atabrine
in the tissues for years, it appears clear to us, from the clinical standpoint,
that some permanent change occurs in the skin of some patients who suffered
from atabrine dermatitis, which causes a dermatitis to persist for years in a
chronic or remittent form. Permanent sweat retention anhidrosis due to occlu-
sion of the sweat ducts has been found following atabrine dermatitis (15, 16,
17). Sulzberger and his group (16, 17) have suggested that occlusion of the sweat
ducts, in the presence of functioning sweat glands, results in multiple and
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repetitious injections of sweat into the subcutaneous tissues as a result of pene-
tration through the walls of the occluded ducts. Allergens or irritants in the
sweat may, they suggest further, cause pathologic changes in the tissues. It is
possible that this, plus other as yet undiscovered metabolic or structural changes
in the skin, may be responsible for persistence of the dermatitis. It is worthy
of note that the course of some of our patients years after the onset has been
similar to that described in the earlier phases of the dermatitis by Livingood
and Dieuaide (2): "a considerable number of these patients have acute 'explo-
sive' generalized exacerbations manifested by oozing eczematoid dermatitis
having a predilection for the fiexors, groins, axillae, extremities and neck."
This we feel, identifies "post-atabrine dermatitis" even more closely with the
parent disease.
CLINICAL DIAGNOSIS OF POST-ATABRINE DERMATITIS
In our first paper (1) we reported the course of post-atabrine dermatitis in a
group of veterans who presented permanent atrophic residua of the skin, hair
follicles or sweat ducts. Parenthetically, it is of interest that Sulzberger and
Baer (4, 11) foresaw at an early date the possibility of permanent skin changes
resulting from atabrine dermatitis. In 1945, they stated "Atrophic and poikilo-
derma-like changes may be largely irreversible. There may be long-lasting or
perhaps permanent atrophic changes". In 1947, they stated "Residua of ata-
brine dermatitis include apparently permanent scarring, alopecias and atrophy,
including that of the sweat gland orifices with consequent anhidrosis and result-
ing profound systemic disturbances due to faulty dissipation of heat". The
group reported was selected because the presence of these atrophic residua
seemed to establish the initial diagnosis of atabrine dermatitis without question.
However, it was pointed out that these patients were a highly selected group,
and their course and prognosis were not representative of the fate of the hundreds
of men who acquired this dermatitis during World War II. In this second paper
thirteen additional veterans are presented who had atabrine dermatitis of less
severe degree, in that only four of them now show mild atrophic residua, and
only nine of them are now suffering from post-atabrine dermatitis. Results of
atabrine patch tests in eight veterans are reported, and there is further observa-
tion of two of the patients presented in our first paper.
Numerous difficulties were encountered in assembling this additional group.
Through the courtesy of Dr. Eugene L. Hamilton, Chief of the Medical Statistics
Division, Office of the Surgeon General, Department of the Army, a list of 144
veterans from the Philadelphia area who had been diagnosed "lichen planus"
or "reaction to malaria prophylaxis" in the Army during 1944—45 was made
available to us. We were able to obtain Veterans Administration claims folders
for only 23 veterans on this list, and in only ten of these were medical records
sufficiently detailed to permit critical evaluation of the diagnosis. Of these ten
only six were available for current observation. The remaining seven patients
were encountered in the routine operation of the Veterans Administration
Regional Office Dermatology Clinic. Thus, this group cannot be considered to
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be a random sample of veterans who had atabrine dermatitis. Even the veterans
on the list supplied by the Surgeon General's office who responded to our request
that they be examined may well have been influenced to come in because of
persistent dermatitis.
From the often excellent and detailed clinical descriptions of the early stages
of the disease available to us, many of these veterans appeared to combine
eczematous and lichenoid features, and none presented clear-cut exfoliative
dermatitis. The course of many of them was apparently similar to that described
and photographed in Goldberg's study (18). Livingood and Dieuaide (2), and
Schmitt (19) have stated that the eczematous type was much more common
than the lichenoid, and Nisbet (10) classified frequency as 80% eczematous,
12% lichenoid and 8 % exfoliative. In discussion of Nisbet's paper, Novy em-
phasized that it is almost impossible to diagnose (as due to atabrine) the eczema-
tous type. Schmitt (19) quotes Livingood as stating "hundreds of persons now
have various types of chronic eczematous eruptions only because they had
quinacrine dermatitis during the war". One gains the impression from Schmitt's
case reports that eczematous dermatitis of the hands and feet first appearing
in the Pacific Theatre is accepted by him as ipso facto evidence for the diagnosis
of atabrine dermatitis. We are unable to accept this concept. Identical lesions
are seen in many patients who have never taken atabrine and have never been
in the tropics, whereas the clinical picture of widespread lichenoid and eczema-
tous dermatitis (so-called atypical lichen planus) is seeii only in patients who
have taken atabrine. Even if it were shown that the incidence of eczematous
dermatitis of the hands and feet was significantly higher in troops in the Pacific
than in troops and civilians in this country, the factors of heat, humidity,
fungous and pyogenic infections, poor skin hygiene and emotional stress might
well be responsible for this difference. Dr. Harvey Blank, who saw many cases
of atabrine dermatitis in the Pacific area, states that the older age groups were
more often affected and that alopecia, violaceous plaques, mucous membrane
lesions, and localization of lesions on the upper eyelids and at the canthi of the
eyes were cardinal diagnostic features (20). We are grateful to Dr. Blank for his
assistance in the selection of our cases.
Retrospective diagnosis of atabrine dermatitis in the absence of atrophic
residua, even when medical records of the acute stage of the disease are available,
is often difficult. In all of the cases presented here lichen planus or atypical
lichen planus was diagnosed by one or more military physicians during the early
stage. It must be recognized, however, that after this entity became known in
the Pacific area, there was a tendency to use this diagnosis rather indiscrimi-
nately, even as the designation "fungous infection" had previously covered
almost the entire range of dermatologic diseases. A number of cases diagnosed
atypical lichen planus in the service were not included in this study because we
did not feel satisfied with the accuracy of the initial diagnosis.
In Table I, the essential findings in this group of 13 veterans is presented.
Twelve of these men were in the Southwest Pacific, one in the China-Burma-
India Theatre. The nine patients in this group without atrophic residua were
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compared with thirteen patients with atrophic residua (nine in our previous
paper, four in the current study), with respect to age at onset, race, duration of
atabrine ingestion, and duration of observation. Table II shows no significant
difference between the two groups. Also, no difference was found in respect to
site of onset, chief site of current cutaneous involvement, and sites of active
lesions at the onset and at the latest examination. Therefore, Table III presents
only the composite findings for the combined groups. It may be noted that the
dermatitis began on the hands in over one-third of the cases, and that oral
mucous membrane lesions were noted in only one-half of the cases during the
acute stage, and in only one-seventh at last examination. The last column of
Table I reveals that of the ten patients with post-atabrine dermatitis, two noted
no seasonal difference, seven had summer exacerbations and one patient experi-
TABLE II
Twenty-two veterans with atabrine dermatitis
VRTERANS WITH
ATROPHIC TOTALS
RESIDUA
White 8 7 15
Colored 5 2 7
Total 13 9 22
Age at onset (mean), years 29.0 30.2 29.5
Duration of atabrine ingestion (mean), months
Before onset of dermatitis 5.1 9.2 6.8
After onset of dermatitis 5.2 6.2 5.6
Total 10.3 15.4 12.4
Duration of observation (mean), years 5.7 6.9 6.2
enced recurrence each summer. Perhaps the greater demands made on struc-
turally or functionally damaged sweat apparatus by warm weather may explain
the baleful effect of heat in eight of the ten patients in this group.
Whether or not these veterans had persistent dermatitis consequent upon
their atabrine dermatitis was not an easy decision to make in all cases. Patients
2 and 4 were considered to show no evidence of post-atabrine dermatitis. How-
ever, the tinea versicolor on the thighs in patient 2 and the hyperhidrotic macera-
tion of the perianal area and feet in patient 4, both of which began after military
service, may be the result of cutaneous changes initiated by atabrine dermatitis.
Conversely, the banal dermatitis of the hands in patient 3 and the anal macera-
tion in patient 6 may not be causally related to the preexisting dermatitis. In
the remainder of the cases we feel we are on firm ground in considering the lesions
as those of post atabrine dermatitis. The lesions of patient 9 are illustrated in
Figure 1.
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TABLE III
Sites of active lesions in 22 veterans with atabrine dermatitis
DURING ACUTE STAGE AT LAST EXAMINATION
SITES OF LESIONS
Site of Sites of Site of major Sites of
onset lesions involvement lesions
Hands 8 16 4 6
Trunk 2 16 1 4
Legs 2 16 3 4
Arms 1 14 1 4
Oral mucous membrane 0 11 1 3
Neck 0 8 3 3
Face (excluding periorbital area) 1 8 0 2
Groin 3 8 0 2
Ears 0 8 0 1
Periorbital area 1 8 0 0
Axillae 0 5 1 2
Feet 3 4 1 3
Penis 0 4 1 2
Scalp 0 4 1 1
Buttocks 0 3 0 0
Anus 0 1 1 3
Scrotum 0 1 0 1
None 0 0 4 4
Fto. 1. Case 9. Six and three-quarters years after onset. Annular sharply outlined flat
shiny lichenoid plaques, recurrent each summer. (Patient of Dr. Thomas Butterworth,
through whose kindness this photograph was made available to us).
S
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A number of these veterans had been examined and treated in the past few
years by competent dermatologists. None had made the diagnosis of chronic
post-atabrine dermatitis. Their diagnoses included erytbema multiforme, solar
dermatitis, urticaria, eczematoid dermatitis, seborrheic dermatitis, neuroder-
matitis, allergic dermatitis, contact dermatitis and lichen planus.
PATCH TESTS W1TH ATABRINE
Atabrine patch tests were applied to normal skin of eight patients, six of
whom had had atabrine dermatitis, and five of whom had, at the time of testing,
lesions of post-atabrine dermatitis. The intact or powdered atabrine tablet was
applied to the normal skin of the shoulder, and left in place under a fixed dressing
for 72 hours or more. In six patients the reaction was negative, in two it was
positive. One of these was T. 0., case 3 in our first study (1), whose subsequent
course is detailed in this paper. The other positive reaction occurred in J. S.,
FIG. 2. Case 1. Reaction to atabrioe patch test seven years and four months after onset
of dermatitis. Four plus reaction with ulceration.
patient 1 in Table I, who developed a 4 plus reaction with ulceration (Fig. 2).
Figure 3 depicts this patient's eczematous lesions of post-atabrine dermatitis
at the time of testing.
Livingood and Dieuaide (2) stated that it is in the eczematous type of ata-
brine dermatitis that the patch test tends to be positive. Sulzberger and Baer
(4) concurred that in patients with eczematous dermatitis or with exfoliative
erythroderma the patch test is often positive, but that in other clinical types it
is usually negative. Bazemore (5), found no significant difference in incidence
of positive tests between patients and controls. Of seven atabrine dermatitis
patients tested on normal skin by Wilson (6), one, who presented a generalized
dry patchy follicular eruption, showed at the site of the atabrine patch test
"a few maculo-papular lesions". The six other patients and four controls all
had negative patch tests. Application of 1:100 atabrine ointment every three
hours for three days to an area of dermatitis resulted in an acute vesicular reac-
tion in three patients with universal subacute atabrine dermatitis. In other
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patients, simultaneous patch tests were positive on areas of present or past
dermatitis, and negative on normal skin. "Only that skin on which there had
previously been an eruption was reactive," Wilson concluded. Agress (7) found
the atabrine patch test to be positive in 2 of 3 patients with atabrine psychosis,
negative in 97 other atabrine treated malaria patients without psychosis or
dermatitis. In three patients with atabrine dermatitis, and in one of twelve
FIG. 3. Case 1. Seven years and four months after onset. Red scaling and crusting in
eyebrows and on cheeks and chin.
patients with other types of dermatitis, the patch test was positive. He con-
cluded that the atabrine patch test showed 3 % false positive reactions in pa-
tients with normal skin and 8.3 % in patients with dermatitis not caused by
atabrine. Peterkin and Hair (8a) stated that skin tests to atabrine (patch,
scratch and intracutaneous) were negative in their series of patients.
CASE REPORTS
Cases 1 and 3 in our first paper (1) have developed acute exacerbations since the time of
publication. Case 1, F. C., whose dermatitis began in July 1943, developed weeping, crusted
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lesions on the abdomen in May 1951. It was during this acute flare that a 72 hour ntabrinc
patch test was negative. In July, a widespread pruritic vesicular and weeping dermntitis
appeared. Skin culture revealed stnphylococcus aureus, slightly sensitive to chloromycetin
and streptomycin and resistant to other antibiotics. Chioromycetin by mouth caused only
temporary improvement, and the patient was hospitalized in September 1951, at which
time generalized elevated crythematous vesicular weeping excoriated plaques were de-
scribed. Cortisone therapy caused prompt and dramatic improvement. Laboratory studies
Fiu. 4. T. 0. Eight years and one month after onset. Weeping and purulent lichenoid
dermatitis in poplitcal fossa.
were within normal limits.* Following discharge from the hospital, cortisone was continued
for two months, in a dosage of 75 to 150 milligrams per day. During this period, multiple
grouped weeping papulovesicles appeared in the lichenoid areas. While the patient was
receiving cortisone, 87.5 milligrams per day, administration of a triple sulfonamide prepa-
ration, 3 grams per day (prescribed because of the nummular character of the eruption)
resulted within 24 hours in massive red edema of the face and mottled crythema on the
chest. Sulfonamide was stopped after 48 hours; cortisone dosage was increased to 150 milli-
* We are grateful to Dr. Philip M. Gottlieb, who cared for the patient in the hospital,
for permission to report his findings.
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grams per day, and the reaction disappeared within a week. In April, 1952, within hours
after subcutaneous injection of procaine for a biopsy, erythema and edema of the face and
neck again developed, and subsided within several days. Monocaine had been used previ-
ously for dental extractions without reaction. In November, 1952, after ingestion of only
10 grams of potassium paraaminobenzoic acid, an acnte eczematous reaction, of ten days
duration, sharply demarcated at the collar line, appeared on the face. In July, 1953, ten
years after the onset, the dermatitis is quite well controlled by local applications of hydro-
cortisone ointment, but flares when treatment is discontinued. (Patient under treatment
by Dr. Walter Shelley).
Sweating studies in the heat cabinet, performed by Dr. Shelley, revealed complete
anhidrosis below the mid chest, with compensatory hyperhidrosis of the face, neck
and shoulders. Symptoms of heat intolerance (quickened heart rate, flushing of face and
and neck, fatigue and anxiety) were elicited on mild elevation of environmental tempera-
Fin. 5. T. 0. Eight years and one month after onset. Lichenoid, scaling, weeping and
crusted plaques.
turc. Inunction of lanolin did not promote the appearance of sweat on the skin, as it does
in anhidrosis due to keratinous plugging of the distal portion of the sweat duct. In order to
determine whether or not the sweat glands in the anhidrotic areas were functional (21),
biopsies were taken from an anhidrotic plaque on the back before and immediately after
a 45 minute period in the heating cabinet. The specimens were stained for glycogen with the
McManus stain. Glycogcn was present in normal abundance in the acinar tissue of the sweat
glands in the specimen taken prior to ssvcating, but was almost completely absent in the
post-sweating sections. Hcmatoxylin and eosin stained sections showed no well-defined
sweat ducts. On the basis of these studies, Dr. Shelley concluded that normally functioning
cccrinc sweat coils were present, but that the sweat was excreted into the corium since it
had no means of egress to the surface. The anhidrosis is irreversible, since it is caused by
destruction of the sweat ducts.
T. 0., case 3 in our first paper (1), whose dermatitis began in April, 1944, developed a
sycosiform pustular process at the nape of the neck in June, 1950. In December, 1951, pop-
litcal pustulation and crusting occurred. In January, 1952, a widespread papular pruritic
dermatitis, marked edema of the face, cars, penis and scrotum, and weeping dermatitis on
the legs appeared. He was hospitalized for a month. Histologic examination showed only a
non-specific chronic dermatitis, and other laboratory studies were normal except for a 5%
4 S
.$ The1
'-'ii
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eosinophilia. On bland local therapy and vitamin A by mouth there was rapid improvement
and on discharge from the hospital, the patient showed only a diffuse dry keratotic folli-
cular dermatitis.* However, within a month the process flared again, and in May examina-
tion revealed multiple widespread lichenoid, scaly, pustular crusted and weeping plaques
(Figs. 4, 5, and 6), and spotty depigmentation without atrophy. The alopecia of the scalp
illustrated in our first paper (1) remained unchanged. A patch test with atabrine at this time
was positive. On hospitalization from May to July, 1952, and following another similar
lichenoid and pustular flare, in September 1953, nine years and five months after the onset,
the dermatitis again responded well to bland therapy.
Fm. 6. T. 0. Eight years and one month after onset. Close-up of sacral plaque in Fig-
ure 5.
DISCUSSION
In this second study we have presented additional evidence of prolonged and
even permanent disability resulting from post-atabrine dermatitis.
Long term manifestations include, in descending order of severity:
(1) Anhidrotic asthenia. F. C. is permanently crippled by his severe wide-
spread complete anhidrosis, which incapacitates him for any physical exertion
in a warm environment.
* IDrs. Lawrence Katzenstein and Herbert Mescon cared for the patient in the hospital.
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(2) Chronic or recurrent lichenoid and eczematous dermatitis. F. C. and T. 0.,
both of whom are suffering from severe and extensive dermatitis over nine years
after the onset, are the most seriously invalided patients with post atabrine
dermatitis we have encountered. It appears probable that their dermatitis will
persist indefinitely, in spite of treatment.
(3) Pruritus with no or minimal dermatitis.
(4) Permanent alopecia. Of cosmetic importance only.
(5) Skin atrophy. Of cosmetic importance only.
We are unable to throw light on the relationship of epidermal sensitization
to atabrine (as demonstrated by a positive patch test), to persistence of derma-
titis. Of the five patients suffering from post-atabrine dermatitis who were
patch tested with atabrine, two had positive reactions and three showed no
reaction. The negative reactors were F. C., and patients 5 and 11 in Table 1.
In all of these active dermatitis was present at the time of testing.
A number of investigators (22—25) have reported cross-sensitization to pro-
caine, sulfonamide and para-aminobenzoic acid, the phenomenon demonstrated
clinically in F. C. In addition Rogers (26) has seen cross-sensitization between
sulfonamide and procaine, and Baer (27) between sulfonamide and para-amino-
benzoic acid. These chemicals contain a primary amino group in the para posi-
tion, and this identity in chemical configuration is considered responsible for
the frequency of cross-sensitization, not only to the three substances to which
F. C. was found reactive, but also to paraphenylenediamine, azo dyes, benzo-
cain, butesin and para-aminosalicylic acid. Baer (27) states that cross-sensitiza-
tion may occur between chemicals with identical or closely related allergenic
components, so that the sensitized cells do not differentiate between them.
Mayer (28) believes that the common property of the various substances in-
volved in cross-sensitization is represented by the metabolic formation of oxida-
tion or reduction products, probably compounds of quinone structure, and that
these metabolites, rather than the original compounds, are the active antigens.
With the exception of the warning by Livingood and Diuaide (2) that patients
with atabrine dermatitis frequently react to sulfonamides, we are not aware of
previous reports of cross-sensitization to para-compounds in patients with
atabrine dermatitis or post-atabrine dermatitis. Atabrine is also a para sub-
stituted compound. It is suggested, therefore, that atabrine may also enter into
cross-sensitization with the above mentioned chemicals, and that search for
group sensitivity should be made in other patients with post-atabrine dermatitis.
The maximum incidence of atabrine dermatitis has been estimated at two
per thousand troops (4). It is probable that most patients who sustained atabrine
dermatitis escaped without permanent disability, and that the number of
veterans seriously disabled as a result of post-atabrine dermatitis is small.
SUMMARY
1. Twenty-two veterans were observed who had had atabrine dermatitis
during World War II.
2. Eighteen of these were suffering from chronic or remittent eczematous or
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liehenoid dermatitis of varying degrees of severity from three nnd a half to ten
years after the onset. Post-atabrine dermatitis is submitted as the name for
this entity.
3. In the great majority the dermatitis was \vorse during the summer.
4. Thirteen patients had atrophic residua of the disease. Four presented per-
manent anhidrosis, eight permanent alopecia and ten cutaneous atrophy. Age,
race, duration of atabrine ingestion and duration of observation could not be
correlated with presence or absence of atrophic residua.
5. Atabrine patch tests were positive in two of five patients with post-atabrine
dermatitis.
6. Hands, feet and groin were the areas most frequently involved initially.
Post-atabrine dermatitis also had a predilection for the hands, and the neck and
legs were next most frequently affected.
7. Incapacitating anhidrotic asthenia, due to permanent widespread complete
anhidrosis, has been observed. The sweat glands were found to be functional,
but because of destruction of the ducts, sweat could not reach the skin surface.
8. The reason for persistence of dermatitis years after contact with the allergen
has been discontinued is not known. It is suggested that escape of sweat into
the cutis as a result of permanent occlusion of the sweat ducts in the presence
of functioning sweat glands may be an etiologic factor.
9. Post-atabrine dermatitis, because of its banal appearance in some, and
despite the bizarre picture in others, is often misdiagnosed, even by experienced
dermatologists.
10. One patient in this study presented cross-sensitivity to procaine, sul-
fonamides and parn-aminobenzoic acid. As atabrine shares para substitution
with these compounds it is suggested that this finding may not be merely coin-
cidental.
CONCLUSION
Post atabrine dermatitis may cause serious and prolonged disability, as a
result of persistent or recurrent eczematous and lichenoid dermatitis, or, less
frequently, as a result of anhidrotic asthenia.
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